Q0ZAH7 AF NFT

Putative K(+) efflux antiporter KefB

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihf3yzur6dthxahztlc4xzkjjt5is4nuvgoe2a2q2l4v4dynadv6e/metadata.json
IPFS of structure file: 
bafybeicly5aipjxnxffcefotlymk4rv6h5fvdmxmk2w6ztgnswwcwdnyvm/AF-Q0ZAH7-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x773dA0745799740C52BA458748cE958D7000D765
First NFT owner address (bech32): 
genesis1wu76qazhn96qc546gkr53n5434cqp4m9ed7fvs
Current NFT ID #201904 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
201904
Accession (UniProt):
Q0ZAH7
Name::
Putative K(+) efflux antiporter KefB
Experimental Method:
Predicted structure
Sequence source:
Alkalimonas amylolytica

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q0ZAH7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q0ZAH7|KEFB_ALKAM Putative K(+) efflux antiporter KefB OS=Alkalimonas amylolytica OX=152573 GN=kefB PE=3 SV=1 MLLDGTLIQLLFLLGFMVFMVMLFQRAHIPASIAYLLVGVLLGAHTAGPVISEGYIHKIAEFGIVFLLFTIGLRFSWQQIYQLRHTILGLGTAQVGLTTLLVALLLWAMGVASVVAFVIGAVFAQSSTTIISKQLLEQGEDQSRHGRLGISLSVFQDITAVPFIIVIPVLGVAMAQDIASTLGMALFKAVLATALVVLVGRYLLRHLFHRVSSSDSAELFTLTVLLVCLAAAWLTQSLGLSMAFGAFLAGMVMGETEFKLQVEAAIRPFRDVLLGIFFVSIGMLLDPMLLPEIGHIALAGALLLLLIKIVLVTALVLATGVALETAFRTGLILAVGGEFGFALLALALEGGTLDSRSSQIILTSVLLSMMLAVFLIRYNLQLSRFVVGRWIGQAAVSSEPFDDIEQHGLQQHVVIAGFGRIGQGVAQFLQKEQVPYIGLDLDAARVKNARLADVPVFYADSTDPDTLIAVGLAKARLLVISHEDLSAALTTLRHARTLHPDLPVIVRTRDESHVAELRQAGATEVIPETIEAGMMLTSHVLLMLNVPARRVNQLVQEQRINRYQLLRQQFRGSADLLKTQQQEQLKAVLLAEGSPAIDQSLQMLDLAQYGIQLTELVRAHNRIEQPSLDMVLQENDVLVLFGSAEALEQASLVLTHRLAAD